Diagnostic Medical Systems (STU:DMS1) Cyclically Adjusted PS Ratio: (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:DMS1 Diagnostic Medical Systems STU:DMS1
51 GF Score
Price €1.04
GF Value €1.12
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Diagnostic Medical Systems Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Diagnostic Medical Systems  (STU:DMS1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Diagnostic Medical Systems Cyclically Adjusted PS Ratio Related Terms


Diagnostic Medical Systems Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Diagnostic Medical Systems's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostic Medical Systems Cyclically Adjusted PS Ratio Chart

Diagnostic Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.43 0.49 0.34 0.59

Diagnostic Medical Systems Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.49 0.00 0.34 0.59

STU:DMS1 vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Diagnostic Medical Systems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnostic Medical Systems Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's Cyclically Adjusted PS Ratio falls into.


STU:DMS1
51GF Score
Diagnostic Medical Systems STU:DMS1
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostic Medical Systems Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Diagnostic Medical Systems's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Diagnostic Medical Systems's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=2.021/120.9000*120.9000
=2.021

Current CPI (Dec25) = 120.9000.

Diagnostic Medical Systems Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 1.888 100.650 2.268
201712 1.710 101.850 2.030
201812 1.509 103.470 1.763
201912 1.924 104.980 2.216
202012 1.988 104.960 2.290
202112 2.250 107.850 2.522
202212 2.188 114.160 2.317
202312 2.081 118.390 2.125
202412 2.023 119.950 2.039
202512 2.021 120.900 2.021

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Diagnostic Medical Systems (STU:DMS1) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be undervalued. The current stock price of €1.04 is trading 7.1% below its estimated GF Value™ of €1.12. GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.

Key valuation signals for STU:DMS1:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €1.12 vs. price of €1.04 (7.1% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the STU:DMS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diagnostic Medical Systems Business Description

Other Exchanges 0RIA:UKALDMS:France
Address 9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
51GF Score

Get the complete analysis for STU:DMS1

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€1.12
GF Value